BRPI0919868B8 - processo para a preparação de um derivado de clorina ou de bacterioclorina - Google Patents

processo para a preparação de um derivado de clorina ou de bacterioclorina

Info

Publication number
BRPI0919868B8
BRPI0919868B8 BRPI0919868A BRPI0919868A BRPI0919868B8 BR PI0919868 B8 BRPI0919868 B8 BR PI0919868B8 BR PI0919868 A BRPI0919868 A BR PI0919868A BR PI0919868 A BRPI0919868 A BR PI0919868A BR PI0919868 B8 BRPI0919868 B8 BR PI0919868B8
Authority
BR
Brazil
Prior art keywords
indicated
pdt
pharmaceutical compositions
methods
bacteriochlorins
Prior art date
Application number
BRPI0919868A
Other languages
English (en)
Portuguese (pt)
Inventor
Stochel Grazynia
Urbanska Krystyna
Guilherme Da Silva Arnaut Moreira Luís
Miguéns Pereira Maria
José Formosinho Sanches Simões Sebastião
Paulo Magalhães Simões Sérgio
Original Assignee
Bluepharma Ind Farmaceutica S A
Univ De Coimbra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bluepharma Ind Farmaceutica S A, Univ De Coimbra filed Critical Bluepharma Ind Farmaceutica S A
Publication of BRPI0919868A2 publication Critical patent/BRPI0919868A2/pt
Publication of BRPI0919868B1 publication Critical patent/BRPI0919868B1/pt
Publication of BRPI0919868B8 publication Critical patent/BRPI0919868B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
BRPI0919868A 2008-10-24 2009-10-22 processo para a preparação de um derivado de clorina ou de bacterioclorina BRPI0919868B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0819594.3 2008-10-24
GBGB0819594.3A GB0819594D0 (en) 2008-10-24 2008-10-24 Process
PCT/PT2009/000057 WO2010047611A1 (en) 2008-10-24 2009-10-22 Process for preparing chlorins and their pharmaceutical uses

Publications (3)

Publication Number Publication Date
BRPI0919868A2 BRPI0919868A2 (pt) 2015-12-15
BRPI0919868B1 BRPI0919868B1 (pt) 2020-10-27
BRPI0919868B8 true BRPI0919868B8 (pt) 2021-05-25

Family

ID=40133817

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919868A BRPI0919868B8 (pt) 2008-10-24 2009-10-22 processo para a preparação de um derivado de clorina ou de bacterioclorina

Country Status (15)

Country Link
US (1) US9670217B2 (OSRAM)
EP (1) EP2346874B1 (OSRAM)
JP (1) JP5567024B2 (OSRAM)
CN (1) CN102227432B (OSRAM)
AU (1) AU2009307106B2 (OSRAM)
BR (1) BRPI0919868B8 (OSRAM)
CA (1) CA2741429C (OSRAM)
DK (1) DK2346874T3 (OSRAM)
ES (1) ES2450136T3 (OSRAM)
GB (1) GB0819594D0 (OSRAM)
PL (1) PL2346874T3 (OSRAM)
PT (1) PT2346874E (OSRAM)
RU (1) RU2513483C2 (OSRAM)
WO (1) WO2010047611A1 (OSRAM)
ZA (1) ZA201102760B (OSRAM)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8524239B2 (en) 2010-07-09 2013-09-03 The United States of America as represented by the Secrectary, Department of Health and Human Services Photosensitizing antibody-fluorophore conjugates
CN103781495A (zh) * 2011-07-11 2014-05-07 美国政府(由卫生和人类服务部的部长所代表) 光敏抗体-荧光团缀合物
US9371555B2 (en) 2012-06-01 2016-06-21 Concordia Laboratories Inc. Lighting systems and methods of using lighting systems for in vitro potency assay for photofrin
CN103721257B (zh) * 2012-10-16 2016-12-21 无锡兆真辐射技术有限公司 光敏素催化分解过氧化氢系列药物
GB201221125D0 (en) 2012-11-23 2013-01-09 Morex Dev Partners Llp Pharmaceutial formulations
WO2014110149A2 (en) * 2013-01-08 2014-07-17 Stoneburner Jon F Method of testing or treating the presence of live viruses
CN106470705B (zh) 2014-08-08 2020-03-31 美国政府(由卫生和人类服务部的部长所代表) 在体内和在体外的靶标的光控移除
US11484593B2 (en) * 2015-03-20 2022-11-01 Luzitin, S.A. Atropisomers of halogenated tetraphenylbacteriochlorins and chlorins and their use in photodynamic therapy
WO2016178191A1 (en) * 2015-05-07 2016-11-10 Luzitin, S.A. Low molecular weight derivatives of carboxamide halogenated porphyrins, namely chlorins and bacteriochlorins, and their applications thereof
CA2994822C (en) 2015-08-07 2023-01-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Near infrared photoimmunotherapy (nir-pit) of suppressor cells to treat cancer
CN108136215B (zh) 2015-08-18 2022-04-29 乐天医药生技股份有限公司 酞菁染料偶联物的制造方法及稳定偶联物
EP3337514B8 (en) 2015-08-18 2022-04-06 Rakuten Medical, Inc. Composition comprising a conjugate comprising a phthalocyanine dye linked to a targeting molecule for photoimmunotherapy
WO2017051435A1 (en) * 2015-09-22 2017-03-30 Council Of Scientific And Industrial Research Chlorin based compounds, a process for preparation thereof and use as photodynamic therapeutic agents and fluorescent probes
US10744212B2 (en) 2016-03-14 2020-08-18 General Electric Company Topical application of nerve labeling dyes for image-guided surgery
WO2018065384A1 (en) * 2016-10-03 2018-04-12 Galderma Research & Development Expression profiles of abc and slc transporters in human and minipig skin, liver and kidney
CN110650962A (zh) * 2017-05-22 2020-01-03 国立大学法人京都大学 四苯基卟啉衍生物
CA3076008A1 (en) * 2017-09-29 2019-04-04 Duke University Fluoro substituted porphyrin compounds, pharmaceutical compositions comprising the same, and methods of preparing and using the same
SG11202011538RA (en) 2018-06-01 2020-12-30 Rakuten Medical Inc Phthalocyanine dye conjugate compositions
CN109912607B (zh) * 2018-12-11 2021-01-22 南华大学 一类卟啉-白杨素复合物及其抗肿瘤活性
CN109651383B (zh) * 2019-01-25 2021-11-16 华东理工大学 用于光敏剂的化合物及其应用
WO2020236818A1 (en) * 2019-05-20 2020-11-26 Nirvana Sciences Inc. Narrow emission dyes, compositions comprising same, and methods for making and using same
RU2725876C1 (ru) * 2019-07-15 2020-07-07 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Производные фторсодержащих хлоринов, проявляющие противоопухолевую активность
WO2022100750A1 (zh) * 2020-11-16 2022-05-19 北京厚燊维康科技有限责任公司 可用于光动力治疗或诊断的制剂
RU2759743C2 (ru) * 2021-04-14 2021-11-17 Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр радиологии» Министерства здравоохранения Российской Федерации (ФГБУ «НМИЦ радиологии» Минздрава России) Способ комбинированного лечения локализованного t1-t2n0m0 рака гортани
JPWO2023022187A1 (OSRAM) * 2021-08-18 2023-02-23
MY208934A (en) * 2021-10-06 2025-06-12 Tunku Abdul Rahman Univ Of Management And Technology Tar Umt Treating skin diseases using a photodynamic therapy (pdt) and a topical agent photosensitizer formulation
CN114813592A (zh) * 2022-03-11 2022-07-29 华南理工大学 一种探究羟基氯喹在自然水体中降解机理的方法
CN114870011B (zh) * 2022-03-24 2023-06-06 深圳大学 一种增强实体瘤内原卟啉ix蓄积的微针贴片及其制备方法
CN119751254B (zh) * 2025-01-13 2025-11-28 浙江工业大学 一种光催化氧化甲烷制备三氟乙酸甲酯的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4562075A (en) 1982-05-20 1985-12-31 Nelson Research & Development Co. Penetration enhancers for transdermal drug delivery of systemic agents
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4218803A (en) 1979-05-25 1980-08-26 Clifford Jack R Implement for cleaning tubular culverts
US5171741A (en) 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5079262A (en) 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
WO1994000118A1 (en) 1992-06-19 1994-01-06 The University Of Toledo Production and use of imines of porphyrins
US5591847A (en) 1994-05-23 1997-01-07 Health Research, Inc. Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages
RU2071320C1 (ru) * 1994-09-29 1997-01-10 Акционерное общество закрытого типа Научно-производственное предприятие "Мелодит" Сенсибилизатор для фотодинамического разрушения клеток злокачественных новообразований
US5648485A (en) 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US5770730A (en) 1996-03-08 1998-06-23 Health Research, Inc. Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
JP2000007693A (ja) * 1998-06-26 2000-01-11 Lederle Japan Ltd クロリン誘導体
JP4796227B2 (ja) 1998-12-09 2011-10-19 イエダ・リサーチ・アンド・デベロツプメント・カンパニー・リミテツド パラジウム置換バクテリオクロロフィル誘導体およびその用途
US6376483B1 (en) 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
GB0121023D0 (en) * 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
PT102721B (pt) * 2002-02-01 2011-01-24 Cipan Companhia Industr Prod De Antibioticos S A Compostos macrocíclicos tetrapirrólicos com rendimento quântico de oxigénio singuleto adequado à terapia fotodinâmica e processos para a sua preparação
FR2877943B1 (fr) * 2004-11-16 2008-09-05 Univ De Coimbra Nouveaux derives de porphyrine, notamment chlorines et/ou bacteriochlorine, et leurs applications en therapie photodynamique
WO2006089122A2 (en) 2005-02-18 2006-08-24 North Carolina State University De novo synthesis of bacteriochlorins
JP5290142B2 (ja) * 2007-02-19 2013-09-18 三栄源エフ・エフ・アイ株式会社 新規な糖連結クロリン誘導体

Also Published As

Publication number Publication date
CN102227432A (zh) 2011-10-26
PL2346874T3 (pl) 2014-05-30
AU2009307106B2 (en) 2015-05-07
US20110250143A1 (en) 2011-10-13
RU2513483C2 (ru) 2014-04-20
RU2011114878A (ru) 2012-11-27
CN102227432B (zh) 2015-04-22
JP2012506425A (ja) 2012-03-15
BRPI0919868A2 (pt) 2015-12-15
GB0819594D0 (en) 2008-12-03
BRPI0919868B1 (pt) 2020-10-27
EP2346874B1 (en) 2013-12-04
ES2450136T3 (es) 2014-03-24
EP2346874A1 (en) 2011-07-27
WO2010047611A9 (en) 2010-07-22
US9670217B2 (en) 2017-06-06
AU2009307106A1 (en) 2010-04-29
DK2346874T3 (en) 2014-03-03
PT2346874E (pt) 2014-03-06
JP5567024B2 (ja) 2014-08-06
CA2741429A1 (en) 2011-04-29
WO2010047611A1 (en) 2010-04-29
CA2741429C (en) 2017-04-18
HK1160848A1 (en) 2012-08-17
ZA201102760B (en) 2012-07-25

Similar Documents

Publication Publication Date Title
BRPI0919868B8 (pt) processo para a preparação de um derivado de clorina ou de bacterioclorina
Kuang et al. Photodecaging of a mitochondria-localized iridium (III) endoperoxide complex for two-photon photoactivated therapy under hypoxia
Li et al. A biotin receptor-targeted silicon (IV) phthalocyanine for in vivo tumor imaging and photodynamic therapy
Zhang et al. Switchable PDT for reducing skin photosensitization by a NIR dye inducing self-assembled and photo-disassembled nanoparticles
Xing et al. Multifunctional divalent vancomycin: the fluorescent imaging and photodynamic antimicrobial properties for drug resistant bacteria
Huang et al. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy
Zhu et al. Comparison between porphin, chlorin and bacteriochlorin derivatives for photodynamic therapy: Synthesis, photophysical properties, and biological activity
Wang et al. Induction of cytotoxicity by photoexcitation of TiO2 can prolong survival in glioma-bearing mice
Negri et al. Photobiomodulation combined with photodynamic therapy using ruthenium phthalocyanine complexes in A375 melanoma cells: Effects of nitric oxide generation and ATP production
Bredell et al. The application and challenges of clinical PD–PDT in the head and neck region: A short review
US8506931B2 (en) Perylenequinone derivatives and uses thereof
BRPI0212172B1 (pt) Agente fotossensibilizante, processo para a preparação de um agente fotossensibilizante, composição farmacêutica, usos de um agente fotossensibilizante ou de um sal farmaceuticamente aceitável do mesmo, e de um agente fotossensibilizante ou de um sal farmaceuticamente aceitável do mesmo e de uma molécula de transferência, métodos para a introdução de uma molécula de transferência no citosol de uma célula in vitro e para diagnose in vitro de anormalidades ou distúrbios através da análise de uma amostra de fluido ou tecido do corpo de um paciente, produto, e, kit para uso em fotoquimioterapia de distúrbios ou anormalidades de superfícies externas ou internas do corpo
de Albuquerque et al. Photodynamic therapy in superficial basal cell carcinoma treatment
CN107899013B (zh) 一种具有光动力学治疗开关效应及分子识别作用的介孔二氧化锰纳米载药系统的制备方法
Serda et al. Synthesis and applications of [60] fullerene nanoconjugate with 5-aminolevulinic acid and its glycoconjugate as drug delivery vehicles
WO2013048022A3 (ko) 수용해도 및 수분산성이 향상된 α-형태의 아연-프탈로시아닌 나노와이어, α-형태의 아연-프탈로시아닌 나노와이어／페노티아진 복합체, 및 이의 제조방법
Wang et al. Folic Acid–Conjugated Pyropheophorbide a as the Photosensitizer Tested for In Vivo Targeted Photodynamic Therapy
BR112013001576A2 (pt) composto tetrapirrólico e composição farmacêutica derivado farmacêuticamente aceitável da mesma e respectivos usos e métodos de terapia fotodinâmica e de diagnóstico e tratamento da artrite e de doenças inflamatórias semelhantes.
Roshanzadeh et al. Next‐Generation Photosensitizers: Cyanine‐Carborane Salts for Superior Photodynamic Therapy of Metastatic Cancer
Guo et al. Self-assembled Camptothecin derivatives–Curcuminoids conjugate for combinatorial chemo-photodynamic therapy to enhance anti-tumor efficacy
Shliakhtsin et al. Pharmacokinetics and biodistribution of Photolon®(Fotolon®) in intact and tumor-bearing rats
Wong et al. Phthalaldehyde-amine capture reactions for bioconjugation and immobilization of phthalocyanines
Sanarova et al. Thiosens liposomal dosage form technology development and photodynamic efficiency assessment
AU2008324033A1 (en) Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias
Mannino et al. Intratumoral vs systemic administration of meta-tetrahydroxyphenylchlorin for photodynamic therapy of malignant gliomas: assessment of uptake and spatial distribution in C6 rat glioma model

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/10/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2745 DE 15-08-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.